GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Haemonetics Corp (STU:HAZ) » Definitions » Ending Cash Position

Haemonetics (STU:HAZ) Ending Cash Position : €164 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Haemonetics Ending Cash Position?

Haemonetics's Ending Cash Position for the quarter that ended in Mar. 2024 was €164 Mil.

Haemonetics's quarterly Ending Cash Position declined from Sep. 2023 (€329 Mil) to Dec. 2023 (€178 Mil) and declined from Dec. 2023 (€178 Mil) to Mar. 2024 (€164 Mil).

Haemonetics's annual Ending Cash Position increased from Mar. 2022 (€236 Mil) to Mar. 2023 (€266 Mil) but then declined from Mar. 2023 (€266 Mil) to Mar. 2024 (€164 Mil).


Haemonetics Ending Cash Position Historical Data

The historical data trend for Haemonetics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haemonetics Ending Cash Position Chart

Haemonetics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 124.27 161.54 235.62 265.69 164.50

Haemonetics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 265.69 263.72 328.89 177.88 164.50

Haemonetics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Haemonetics's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=261.709+-97.213
=164

Haemonetics's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=178.46+-13.964
=164


Haemonetics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Haemonetics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Haemonetics (STU:HAZ) Business Description

Traded in Other Exchanges
Address
125 Summer Street, Boston, MA, USA, 02110
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Haemonetics (STU:HAZ) Headlines

No Headlines